AKKARAJU SRINIVAS 4
4 · vTv Therapeutics Inc. · Filed Jun 29, 2026
Research Summary
AI-generated summary of this filing
vTv Therapeutics Director Akkaraju Srinivas Receives 6,000-Share Award
What Happened
- Akkaraju Srinivas, a director of vTv Therapeutics, was granted a derivative equity award for 6,000 shares on 2026-06-26. The award is reported at $35.08 per share, for a total reported value of $210,480. This is a grant/award (not an open-market purchase or sale).
Key Details
- Transaction date and price: 2026-06-26; 6,000 shares at $35.08 each; total $210,480.
- Transaction type: Award/grant (derivative), reported on Form 4 filed 2026-06-29.
- Vesting note: The award vests on the earlier of June 26, 2027 and the date of the 2027 annual meeting of shareholders, subject to continued board service.
- Shares owned after transaction: Not specified in the information provided.
- Filing timeliness: Form 4 filed 2026-06-29; appears to be a timely filing (no late-filing flag indicated).
Context
- This was a compensation-related award to a director rather than a cash purchase; such grants are common for board members and are tied to continued service via vesting conditions. Because it is a derivative award with vesting, it does not represent an immediate market purchase and should not be interpreted as a direct buy/sell signal.
Insider Transaction Report
Form 4
AKKARAJU SRINIVAS
Director
Transactions
- Award
Director stock option (right to buy)
[F1]2026-06-26$35.08/sh+6,000$210,480→ 16,983 totalExercise: $35.08Exp: 2036-06-26→ Class A Common Stock (6,000 underlying)
Footnotes (1)
- [F1]The option vests on the earlier of June 26, 2027, and the date of the 2027 annual general meeting of shareholders, subject to the director's continued service on the board of directors through such vesting.
Signature
/s/ Elizabeth Keiley, as Attorney-in-fact|2026-06-29